MDT and patient perspectives on real-world use of antihyperglycemic therapies to manage T2D and obesity episode artwork

EPISODE · Oct 13, 2021 · 19 MIN

MDT and patient perspectives on real-world use of antihyperglycemic therapies to manage T2D and obesity

from touchPODCAST · host touchpodcast

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient discuss real-world use of antihyperglycemic therapies to achieve an effective combination of glycemic control, weight loss and cardiovascular benefits.  The multidisciplinary team and patient Diabetes nurse practitioner: Dr Shannon Idzik, USA Primary care specialist: Professor Stewart Harris, Canada Patient: Tammie Snowden, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchendocrinologyime.org/antihyperglycemic-therapy-in-T2D-obesity-MDT-outlook//

Episode metadata supplied by the publisher feed · Published Oct 13, 2021

Embed this episode

Ready to play

MDT and patient perspectives on real-world use of antihyperglycemic therapies to manage T2D and obesity

0:00 19:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 19 minutes long.

When was this touchPODCAST episode published?

This episode was published on October 13, 2021.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!